ArticleCancer chemotherapy and pharmacology2014

A phase 1 study of the BCL2-targeted deoxyribonucleic acid inhibitor (DNAi) PNT2258 in patients with advanced solid tumors.

Anthony W Tolcher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.